معرفی
Rhiannon Baggott is an academic researcher specializing in immunology, rheumatology, and post-COVID-19 health outcomes. Her work focuses on disease mechanisms, clinical management of rheumatoid arthritis, and recovery from severe respiratory conditions. She collaborates extensively with multidisciplinary teams across the UK, contributing to large-scale studies like the PHOSP-COVID initiative and the TITRATE research programme. Her expertise aligns with UN Sustainable Development Goals related to health and well-being.
Research interests include immune ageing in viral infections, post-hospitalization recovery dynamics, and optimizing treatment protocols for chronic autoimmune conditions. Her collaborative projects address critical gaps in understanding long-term effects of diseases such as rheumatoid arthritis and SARS-CoV-2 infection.
Key contributions include studies on accelerated immune ageing linked to severe COVID-19, determinants of post-acute dyspnoea recovery, and sleep’s role in lung function post-hospitalization. Her work bridges clinical practice and translational research, aiming to improve patient outcomes through evidence-based interventions.
Baggott is part of major research consortia, including the PHOSP-COVID Study and ISARIC4C Investigators, reflecting her role in global health research networks. She has published in high-impact journals such as Immunity and Ageing, The Lancet Regional Health, and Seminars in Arthritis and Rheumatism.